Anti-IL12A antibody

  • Description

  • Application Data


An antibody raised against the cytokine interleukin 12 subunit (IL12 p35) encoded by IL12A; a growth factor for active T and natural killer (NK) cells and induces interferon gamma INF-γ production.

See full description

Application Data

Catalogue number crb2005604
Antibody Anti-IL12A antibody
Antigen Peptide KLH conjugated synthetic peptide crb1200808e
Protein ID P29459
Aliases Interleukin-12 subunit alpha, IL-12A, CLMF p35, IL-12 subunit p35, NK cell stimulatory factor chain 1, NKSF1
Host Species Rabbit
Antibody Type Polyclonal
Concentration 1mg/ml
Target IL12A
Storage Stabilisers The product should be stored at -20°C for short term storage and long term storage. Avoid repeated freeze/ thaw cycles.
Storage The product should be stored at -20°C for short term storage and long term storage. Avoid repeated freeze/ thaw cycles.

Goris et al., (2012). Progress in multiple sclerosis genetics. Curr. genomics, 13(8): 646. PMID: 23730204.


Hirschfield et al., (2009). Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. NEJM., 360(24): 2544. DOI: 10.1056/NEJMx090024.


Kappen et al., (2015). Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Behçet disease. PloS one, 10(3): e0119085.

Material Safety Data Sheet (MSDS)

IL12 is a heterodimer connected by a disulphide bond, one is encoded by IL12A and another IL12B. IL12 acts upon T cells inducing their differentiation; the interleukin induces production of INF-γ in resting peripheral blood mononuclear cells (PBMC). Furthermore, IL12 acts as a growth factor for activated T and natural killer (NK) cells, while enhancing the lytic activity of NK/lymphokine-activated killer cells. IL12 promotes T cell migration to the central nervous system by upregulating adhesion molecules – P-selectin glycoprotein ligand (PSGL-1) and chemokine receptor (CCR5).

Mutations in IL12A have been associated with Behcet Syndrome and Primary Biliary Cholangitis. IL12 also appears to play a role in multiple sclerosis pathogenesis.  However, studies have shown administering ranges of IL12 doses can have a differential effect on cancer and virus response possibly due to IL12 and CD8+ T cell signal transduction during cancer surveillance. Use of this antibody against IL12 subunit alpha could further the research into the protein’s role in the immune response and signalling cascade.

Anti-IL12A antibody

Cat No.Pack SizePriceQty.
Bulk Quote